Friday, May 24, 2019
wellness India Expo
Home Tags Biopharma

Tag: biopharma

Takeda announces Andrey Potapov as ICMEA Area Head

Potapov’s appointment follows Takeda’s recent acquisition of Shire Pharmaceuticals – enabling Takeda to become a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan...............

Record 59 new US drugs launched in 2018, success rates fall:...

As per the study by IQVIA Institute for Human Data Science, while the likelihood that a drug entering clinical development would be a success was 11 percent, down from 14 percent in 2017, eight identified trends could increase R&D productivity by double digits during next five years.................

Syngene International & BIRAC set up Centre for Advanced Protein Studies

The Centre has been set up at Syngene’s campus in Bengaluru by the Biotechnology Industry Research Assistance Council (BIRAC) and will host a state-of-the-art GLP accredited analytical laboratory. The collaboration a part of National Biopharma Mission.............

Lupin Bioresearch Centre completes fifth successful US-FDA inspection

Lupin Bioresearch Centre (LBC) conducts the in-vivo and in-vitro bioequivalence studies for Lupin in Pune...................

Merck launches cutting edge fertility technologies in India

With improved assisted reproductive technology (ART) through higher precision, Merck offers a combined portfolio of drugs and technologies........................

16th edition of BioAsia 2019 kicks off at Hyderabad

On the first day, the Genome Valley Excellence Award 2019 was presented to Dr Don W. Cleveland of the University of California recognizing his pioneering work in cancer genetics. Also, the Governor of Telangana launched State government’s Vaccine Skilling program...………….

4677 generic medicine centres made functional by the end of 2018

As per the union government, unbranded generic medicines worth Rs 417 crores (MRP) have been sold through 4677 ‘Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana’ (PMBJP) Kendras that are functional in 35 States/UTs of the country...………..

India seeks greater market access for agri & pharma products in...

The top commerce ministry officials of India and China discussed the various issues related to commercial transactions between two nations including widening trade deficit...……….

US-China trade war offers window of opportunity for Indian pharma sector

As per the leading data and analytics company GlobalData, the standoff between China and India over regulatory issues provides great opportunity for the Indian pharma firms to penetrate the Chinese healthcare market and reduce trade deficit...………..

Telangana govt proposes a mega biopharma hub at Genome Valley

The proposed facility, to come up with an estimated cost of Rs 60 crore, will be set up through Public Private Partnership in Genome Valley, which is India's first organised cluster for life sciences R&D and clean manufacturing activities.